Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA

Cell Research

Volumn 14, Issue 6, 2004, Pages 473-479

  Li, Chang You ^a   Chu, Jia You ^a   Yu, Jian Kun ^a   Huang, Xiao Qin ^a   Liu, Xiao Juan ^a   Shi, Li ^a   Che, Yan Chun ^a   Xie, Jiu Yong ^b  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alternative splicing; bcl x gene; Cytokine; Pre mRNA element; TPA

Indexed keywords

BCL2L1 PROTEIN, HUMAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN BCL X; RNA PRECURSOR;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL STRAIN K 562; DRUG EFFECT; EXON; GENETICS; HUMAN; INTRON; METABOLISM; PHYSIOLOGY; REPORTER GENE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; BCL-X PROTEIN; CELL LINE, TUMOR; EXONS; GENES, REPORTER; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; INTRONS; K562 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA PRECURSORS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 21644486225     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290250     Document Type: Article

References (31)

1. Black DL. Mechanisms of Alternative Pre-Messenger RNA Splicing. Annu Rev Biochem 2003; 72:291-336.
2. Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet 2002; 30:13-9.
3. Black DL. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 2000; 103:367-70.
4. Grabowski PJ, Black DL. Alternative RNA splicing in the nervous system. Prog Neurobiol 2001; 65:289-308.
5. Konig H, Ponta H, Herrlich P. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J 1998; 17:2904-13.
6. Lynch KW, Weiss A. A model system for activation-induced alternative splicing of CD45 pre- mRNA in T cells implicates protein kinase C and Ras. Mol Cell Biol 2000; 20:70-80.
7. Weg-Remers S, Ponta H, Herrlich P, Konig H. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J 2001; 20:4194-203.
8. Xie J, Black DL. A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature 2001; 410:936-9.
9. Rothrock C, Cannon B, Hahm B, Lynch KW. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. Mol Cell 2003; 12:1317-24.
10. Matter N, Herrlich P, Konig H. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 2002; 420:691-5.
11. Jiang ZH, Wu JY. Alternative splicing and programmed cell death. Proc Soc Exp Biol Med 1999; 220:64-72.
12. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003; 39:615-47.
13. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597-608.
14. Gonzalez-Garcia M, Garcia I, Ding L, et al. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A 1995; 92:4304-8.
15. Motoyama N, Wang F, Roth KA, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x- deficient mice. Science 1995; 267:1506-10.
16. Reed JC. Splicing and dicing apoptosis genes. Nat Biotechnol 1999; 17:1064-5.
17. Mercatante DR, Bortner CD, Cidlowski JA, Kole R. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells, analysis of apoptosis and cell death. J Biol Chem 2001; 276:16411-7.
18. Taylor JK, Zhang QQ, Wyatt JR, Dean NM. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat Biotechnol 1999; 17:1097-100.
19. Gonzalez-Garcia M, Perez-Ballestero R, Ding L, et al. bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 1994; 120:3033-42.
20. Xerri L, Parc P, Brousset P, et al. Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas. Br J Haematol 1996; 92:900-6.
21. Chalfant CE, Rathman K, Pinkerman RL, et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 2002; 277:12587-95.
22. Liu H, Ma Y, Li Z, et al. Cloning, expression and purification of human interleukin 6. J N Bethune Univ Med Sci 1999; 25:14-7 (In Chinese).
23. Li Z, Ji Q, Zhou L, et al. Purification of recombinant human granulocyte-macrophage colony stimulating factor expressed in Escherichia coli cells. Yunnan Med J 2001, 22:1-3 (In Chinese).
24. Xu G, Zhang L, Shen H, Hu C. Inhibition of protein kinase C by scutellarein and its analogues. Acta Academiae Medicinae Shanghai 1993; 20:187-91 (In Chinese).
25. Zhu BH, Guan YY, He H, Lin MJ. Erigeron breviscapus prevents defective endothelium-dependent relaxation in diabetic rat aorta. Life Sci 1999; 65:1553-9.
26. Grillot DA, Gonzalez-Garcia M, Ekhterae D, et al. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 1997; 158:4750-7.
27. Burge CB, Padgett RA, Sharp PA. Evolutionary fates and origins of U12-type introns. Mol Cell 1998; 2:773-85.
28. Geijsen N, Koenderman L, Coffer PJ. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev 2001; 12:19-25.
29. Grad JM, Zeng XR, Boise LH. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 2000; 12:543-9.
30. Pecci A, Viegas LR, Baranao JL, Beato M. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-x gene. J Biol Chem 2001; 276:21062-9.
31. Maquat LE, Carmichael GG. Quality control of mRNA function. Cell 2001; 104:173-6.